Obesity: Genes, brain, gut, and environment

Nutrition

Volumn 26, Issue 5, 2010, Pages 459-473

  Das, Undurti N ^a,b  

^a UND LIFE SCIENCES   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Cytokines; Genes; Ghrelin; Gut bacteria; Hypothalamus; Leptin; Neuropeptide Y; Obesity

Indexed keywords

ACETYLCHOLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; COENZYME A; ENDOCANNABINOID; GHRELIN; GLUCOSE; INCRETIN; INSULIN; LEPTIN; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A; MELANOCORTIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; CALORIC INTAKE; DIGESTION; DISEASE PREDISPOSITION; ENERGY BALANCE; FETUS GROWTH; FOOD INTAKE; GENE EXPRESSION PROFILING; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOTHALAMUS DISEASE; INFLAMMATION; INSULIN RELEASE; INTESTINE FLORA; ISCHEMIC HEART DISEASE; LIVER FUNCTION; METABOLIC BALANCE; MOLECULAR GENETICS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; REVIEW; SATIETY; SIGNAL TRANSDUCTION; SOLID TUMOR; STOMACH BYPASS; VAGUS NERVE;

ANIMALS; BACTERIA; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIABETES MELLITUS, TYPE 2; DIGESTION; ENERGY INTAKE; ENVIRONMENT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPOTHALAMIC DISEASES; IMMUNITY; INSULIN; INSULIN-SECRETING CELLS; INTESTINES; LIVER; MALE; OBESITY; VAGUS NERVE;

MUS;

EID: 77951207195     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.09.020     Document Type: Review

References (157)

1. Davis M.M., McGonagle K., Schoeni R.F., Stafford F. Grandparental and parental obesity influences on childhood overweight: implications for primary care practice. J Am Board Fam Med 2008, 21:549-554.
2. Eckel R.H. Obesity and heart disease. Circulation 1997, 96:3248-3250.
3. Schultz L.O., Schoeller D.A. A compilation of total daily energy expenditures and body weights in healthy adults. Am J Clin Nutr 1994, 60:676-681.
4. Kimm S.Y., Glynn N.W., Aston C.E., Damcott C.M., Poehlman E.T., Daniels S.R., Ferrell R.E. Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr 2002, 75:714-719.
5. Yanovski J.A., Diament A.L., Sovik K.N., Nguyen T.T., Li H., Sebring N.G., Warden C.H. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr 2000, 71:1405-1420.
6. Kovacs P., Lehn-Stefan A., Stumvoll M., Bogardus C., Baier L.J. Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes 2003, 52:1292-1295.
7. Ruige J.B., Ballaux D.P., Funahashi T., Mertens I.L., Matsuzawa Y., Van Gaal L.F. Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders. Am J Clin Nutr 2005, 82:21-25.
8. Krakoff J., Ma L., Kobes S., Knowler W.C., Hanson R.L., Bogardus C., Baier L.J. Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes 2008, 57:3267-3272.
9. Gomez-Ambrosi J., Catalan V., Diez-Caballero A., Martinez-Cruz L.A., Gil M.J., Garcia-Foncillas J., et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004, 18:215-217.
10. Das U.N. Perinatal nutriiton and obesity. Br J Nutr 2008, 99:1391-1392.
11. Das U.N. Perinated supplementation of long-chain polyunsaturated fatty acids, immune response, and adult diseases. Med Sci Monit 2004, 10:19-25.
12. Das U.N. Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period?. J Nutr Biochem 2007, 18:701-713.
13. Adam C.L., Findlay P.A., Chanet A., Aitken R.P., Milne J.S., Wallace J.M. Expression of energy balance regulatory genes in the developing ovine fetal hypothalamus at midgestation and the influence of hyperglycemia. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1895-R1900.
14. Das U.N. A perinatal strategy for preventing adult disease: the role of long-chain polyunsaturated fatty acids 2002, Kluwer Academic Publishers, Boston.
15. Barker D.J., Hales C.N., Fall C.H., Osmond C., Phipps K., Clark P.M. Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
16. Lucas A., Fewtrell M.S., Cole T.J. Fetal origins of adult disease-the hypothesis revisited. BMJ 1999, 319:245-249.
17. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
18. Gold R.M., Quackenbush P.M., Kapatos G. Obesity following combination of rostrolateral to VMH cut and contralateral mammillary area lesion. J Comp Physiol Psychol 1972, 79:210-218.
19. King B.M., Smith R.L., Frohman L.A. Hyperinsulinemia in rats with ventromedial hypothalamic lesions: role of hyperphagia. Behav Neurosci 1984, 98:152-155.
20. Funahashi T., Shimomura I., Hiraoka H., Arai T., Takahashi M., Nakamura T., et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 1995, 211:469-475.
21. Paes A.M., Carniatto S.R., Francisco F.A., Brito N.A., Mathias P.C. Acetylcholinesterase activity changes on visceral organs of VMH lesion-induced obese rats. Int J Neurosci 2006, 116:1295-1302.
22. Sakaguchi T., Bray G.A., Eddlestone G. Sympathetic activity following paraventricular or ventromedial hypothalamic lesions in rats. Brain Res Bull 1988, 20:461-465.
23. Cox J.E., Powley T.L. Prior vagotomy blocks VMH obesity in pair-fed rats. Am J Physiol Endocrinol Metab 1981, 240:E573-E583.
24. Uno K., Katagiri H., Yamada T., Ishigaki Y., Ogihara T., Imai J., et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 2006, 312:1656-1659.
25. Gautam D., Han S.J., Duttaroy A., Mears D., Hamdan F.F., Li J.H., et al. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes Metab 2007, 9(Suppl 2):158-169.
26. Edvell A., Lindstrom P. Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am J Physiol Endocrinol Metab 1998, 274(6 Pt 1):E1034-E1039.
27. Kiba T., Tanaka K., Hoshino M., Misugi K., Inoue S. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology 1996, 110:885-893.
28. Imai J., Katagiri H., Yamada T., Ishigaki Y., Suzuki T., Kudo H., et al. Regulation of pancreatic β cell mass by neuronal signals from the liver. Science 2008, 322:1250-1254.
29. Thaler J.P., Cummings D.E. Food alert. Nature 2008, 452:941-942.
30. Wang P.Y.T., Caspi L., Lam C.K.L., Chari M., Li X., Light P.E., et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008, 452:1012-1016.
31. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., et al. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000, 46:688-693.
32. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.P., Bortoluzzi M.N., et al. The stomach is a source of leptin. Nature 1998, 394:790-793.
33. Barrachina M.D., Martinez V., Wang L., Wei J.T., Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in mice. Proc Natl Acad Sci U S A 1997, 94:10455-10460.
34. Fox E.A., Murphy M.C. Factors regulating vagal sensory development: potential role in obesities of developmental origin. Physiol Rev 2008, 94:90-104.
35. Komori T., Morikawa Y., Nanjo K., Senba E. Induction of brain-derived neurotrophic factor by leptin in the ventromedial hypothalamus. Neuroscience 2006, 139:1107-1115.
36. Hirano H., Day J., Fibiger H.C. Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 1995, 65:1139-1145.
37. Zhou F.M., Liang Y., Dani J.A. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 2001, 4:1224-1229.
38. Bartness T.J., Kay Song C., Shi H., Bowers R.R., Foster M.T. Brain-adipose tissue cross talk. Proc Nutr Soc 2005, 64:53-64.
39. Huang L.Z., Winzer-Serhan U.H. Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups. Dev Neurobiol 2007, 67:363-377.
40. Obici S., Feng Z., Morgan K., Stein D., Karkanias G., Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002, 51:271-275.
41. Obici S., Feng Z., Arduini A., Conti R., Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003, 9:756-761.
42. Lam T.K., Pocai A., Gutierrez-Juarez R., Obici S., Bryan J., Aquilar-Bryan L., et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 2005, 11:320-327.
43. Suresh Y., Das U.N. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2001, 64:37-52.
44. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 2003, 19:93-114.
45. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition 2003, 19:213-228.
46. Suresh Y., Das U.N. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2006, 74:199-213.
47. Richard D., Guesdon B., Timofeeva E. The brain endocannabinoid system in the regulation of energy balance. Best Pract Res Clin Endocrinol Metab 2009, 23:17-32.
48. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 2008, 51:1356-1367.
49. Romanova I.V., Ramos E.J., Xu Y., Quinn R., Chen C., George Z.M., et al. Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg 2004, 199:887-895.
50. Xu Y., Ramos E.J., Middleton F., Romanova I., Quinn R., Chen C., et al. Gene expression profiles post Roux-en-Y gastric bypass. Surgery 2004, 136:246-252.
51. Tonra J.R., Ono M., Liu X., Garcia K., Jackson C., Yancoupoulos G.D., et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes 1999, 48:588-594.
52. Ono M., Itakura Y., Nonomura T., Nakagawa T., Nakayama C., Taiji M., Noguchi H. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 2000, 49:129-133.
53. Cao L., Lin E.-J.D., Cahill M.C., Wang C., Liu X., During M.J. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat Med 2009, 15:447-454.
54. Nonomura T., Tsuchida A., Ono-Kishino M., Nakagawa T., Taiji M., Noguchi H. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int J Exp Diabetes Res 2001, 2:201-209.
55. Suwa M., Kishimoto H., Nofuji Y., Nakano H., Sasaki H., Radak Z., Kumagai S. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 2006, 55:852-857.
56. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50:431-438.
57. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003, 6:736-742.
58. Das U.N. Is type 2 diabetes mellitus a disorder of the brain?. Nutrition 2002, 18:667-672.
59. Tran P.V., Akana S.F., Malkovska I., Dallman M.F., Parada L.F., Ingraham H.A. Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. J Comp Neurol 2006, 498:637-648.
60. Obici S., Feng Z., Tan J., Liu L., Karkanias G., Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Invest 2001, 108:1079-1085.
61. Tamura H., Kamegai J., Shimizu T., Ishii S., Sugihara H., Oikawa S. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 2002, 143:3268-3275.
62. Kamegai Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50:2438-2443.
63. Saad M.F., Bernaba B., Hwu C.M., Jinagouda S., Fahmi S., Kogosov E., Boyadjian R. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002, 87:3997-4000.
64. Broglio F., Gottero C., Van Koetsveld P., Prodam F., Destefanis S., Benso A., et al. Acetylcholine regulates ghrelin secretion in humans. J Clin Endocrinol Metab 2004, 89:2429-2433.
65. Dardennes R.M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., et al. Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 2007, 32:106-113.
66. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
67. Huang Q., Viale A., Picard F., Nahon J., Richard D. Effects of leptin on melanin-concentrating hormone expression in the brain of lean and obese Lep(ob)/Lep(ob) mice. Neuroendocrinology 1999, 69:145-153.
68. Das U.N. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002, 18:430-432.
69. Das U.N. Aberrant expression of perilipins and 11-β-HSD-1 as molecular signatures of metabolic syndrome X in South East Asians. J Assoc Phys India 2006, 54:637-649.
70. Sinha S., Rathi M., Misra A., Kumar V., Kumar M., Jagannathan N.R., et al. Subclinical inflammation and soleus muscle intramyocellular lipids in healthy Asian Indian males. Clin Endocrinol (Oxf) 2005, 63:350-355.
71. Das U.N. A perinatal strategy to prevent coronary heart disease. Nutrition 2002, 19:1022-1027.
72. Albert M.A., Glynn R.J., Ridker P.M. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003, 108:161-165.
73. van der Meer I.M., de Maat M.P., Hak A.E., Kilian A.J., Del Sol A.I., Van Der Kuip D.A., et al. C-reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam study. Stroke 2002, 33:2750-2755.
74. Luc G., Bard J.-M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., et al. C-reactive protein, interleukins-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol 2003, 23:1255-1261.
75. Engstrom G., Hedblad B., Stavenow L., Lind P., Janzon L., Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097-2101.
76. Barzilay J.I., Abraham L., Heckbert S.R., Cushman M., Kuller L.H., Resnick H.E., Tracy R.P. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001, 50:2384-2389.
77. Kim M.J., Yoo K.H., Park H.S., Chung S.M., Jin C.J., Lee Y., et al. Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus. Yonsei Med J 2005, 46:42-50.
78. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003, 107:391-397.
79. Liu S., Manson J.E., Buring J.E., Stampfer M.J., Willett W.C., Ridker P.M. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75:492-498.
80. Pepys M.B., Hirshfiled G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
81. Griselli M., Herbert J., Hutchinson W.L., Taylor K.M., Sohail M., Krausz T., Pepys M.B. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999, 190:1733-1739.
82. Gill R., Kemp J.A., Sabin C., Pepys M.B. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab 2004, 24:1214-1218.
83. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006, 440:1217-1221.
84. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation 2002, 106:2067-2072.
85. Kirwan J.P., Krishnan R.K., Weaver J.A., Del Aguila L.F., Evans W.J. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab 2001, 281:E1137-E1143.
86. Lin Y., Rajala M.W., Berger J.P., Moller D.E., Barzilai N., Scherer P.E. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001, 276:42077-42083.
87. Cho H.J., Kim J.K., Zhou X.F., Rush R.A. Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res 1997, 764:269-272.
88. Oddiah D., Anand P., McMahon S.B., Rattray M. Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 1998, 9:1455-1458.
89. Virchow J.C., Julius P., Lommatzsch M., Luttmann W., Renz H., Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998, 158:2002-2005.
90. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 1999, 189:865-870.
91. Tabakman R., Lecht S., Sephanova S., Arien-Zakay H., Lazarovici P. Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. Prog Brain Res 2004, 146:387-401.
92. Makar T.K., Trisler D., Sura K.T., Sultana S., Patel N., Bever C.T. Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. J Neurol Sci 2008, 270:70-76.
93. Ricci A., Mariotta S., Saltini C., Falasca C., Giovagnoli M.R., Mannino F., et al. Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22:186-194.
94. Hahn C., Islamian A.P., Renz H., Nockher W.A. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol 2006, 117:787-794.
95. Bennedich Kahn L., Gustafsson L.E., Olgart Hoglund C. Brain-derived neurotrophic factor enhances histamine-induced airway responses and changes levels of exhaled nitric oxide in guinea pigs in vivo. Eur J Pharmacol 2008, 595:78-83.
96. Lommatzsch M., Braun A., Mannsfeldt A., Botchkarev V.A., Botchkarev N.V., Paus R., et al. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Am J Pathol 1999, 155:1183-1193.
97. Rost B., Hanf G., Ohnemus U., Otto-Knapp R., Groneberg D.A., Kunkel G., Noga O. Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. Regul Pept 2005, 124:19-25.
98. Noga O., Englmann C., Hanf G., Grutzkau A., Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy 2003, 33:649-654.
99. Rihl M., Kruithof E., Barthel C., De Keyser F., Veys E.M., Zeidler H., et al. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment. Ann Rheum Dis 2005, 64:1542-1549.
100. del Porto F., Aloe L., Lagana B., Triaca V., Nofroni I., D'Amelio R. Nerve growth factor and brain-derived neurotrophic factor levels in patients with rheumatoid arthritis treated with TNF-alpha blockers. Ann N Y Acad Sci 2006, 1069:438-443.
101. Grimsholm O., Guo Y., Ny T., Forsgren S. Expression patterns of neurotrophins and neurotrophin receptors in articular chondrocytes and inflammatory infiltrates in knee joint arthritis. Cells Tissues Organs 2008, 188:299-309.
102. Cai D., Holm J.M., Duignan I.J., Zheng J., Xaymardan M., Chin A., et al. BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiol Genomics 2006, 24:191-197.
103. Johansson M., Norrgard O., Forsgren S. Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis. Inflamm Bowel Dis 2007, 13:398-409.
104. di Mola F.F., Friess H., Zhu Z.W., Koliopanos A., Bley T., Di Sebastiano P., et al. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 2000, 46:670-679.
105. Raap U., Werfel T., Goltz C., Deneka N., Langer K., Bruder M., et al. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 2006, 61:1416-1418.
106. Bajzer M., Seeley R.J. Obesity and gut flora. Nature 2006, 444:1009-1010.
107. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
108. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
109. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
110. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.L. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-11075.
111. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723.
112. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007, 104:979-984.
113. Varel V.H., Pond W.G., Pekas J.C., Yen J.T. Influence of high-fibre diet on bacterial populations in gastrointestinal tracts of obese- and lean-genotype pigs. Appl Environ Microbiol 1982, 44:107-112.
114. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008, 105:16767-16772.
115. Amar J., Burcelin R., Ruiavets J.B., Cani P.D., Fauvel J., Alessi M.C., et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008, 87:1219-1223.
116. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009, 106:2365-2370.
117. Whitson B.A., D'Cunha J., Hoang C.D., Wu B., Ikramuddin S., Buchwald H., et al. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells. Surg Obes Relat Dis 2009, 5:181-193.
118. Das U.N. Is metabolic syndrome X a disorder of the brain?. Curr Nutr Food Sci 2008, 4:73-108.
119. Middleton F.A., Ramos E.J.B., Xu Y., Diab H., Zhao X., Das U.N., Meguid M.M. Application of genomic technologies: DNA microarrays and metabolic profiling of obesity in the hypothalamus and in subcutaneous fat. Nutrition 2004, 20:14-25.
120. Meguid M., Ramos E.J.B., Suzuki S., Xu Y., George Z.M., Das U.N., et al. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg 2004, 8:621-630.
121. Das U.N. Metabolic syndrome X is a low-grade systemic inflammatory condition with its origins in the perinatal period. Curr Nutr Food Sci 2007, 3:277-295.
122. Das U.N. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 2005, 21:762-773.
123. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
124. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004, 21:1457-1467.
125. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C., Arnold J.T., Rapoport S.I., Bazinet R.P. N-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007, 12:36-46.
126. Innis S.M., de La Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 2001, 131:118-122.
127. de La Presa Owens S., Innis S.M. Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 2000, 48:125-130.
128. Peters J.H., Simasko S.M., Ritter R.G. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin. Physiol Behav 2006, 89:477-485.
129. Ueno N., Dube M.G., Inui A., Kalra P.S., Kalra S.P. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 2004, 145:4176-4184.
130. Goto M., Arima H., Watanabe M., Hayashi M., Banno R., Sato I., et al. Ghrelin increases neuropeptide Y and agouti-related peptide gene expression in the arcuate Nucleus in rat hypothalamic organotypic cultures. Endocrinology 2006, 147:5102-5109.
131. Bassil A.K., Dass N.B., Sanger G.J. The prokinetic-like activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurones. Eur J Pharmacol 2006, 544:146-152.
132. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
133. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002, 195:781-788.
134. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-387.
135. Hersi A.I., Kitaichi K., Srivastava L.K., Gaudreau P., Quirion R. Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Res Mol Brain Res 2000, 76:336-340.
136. Das U.N. Alcohol consumption and risk of dementia. Lancet 2002, 360:490.
137. Minami M., Kimura S., Endo T., Hamaue N., Horafuji M., Togashi H., et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997, 58:1123-1129.
138. Borkman M., Stolien L.H., Pan D.A., Jenkins A.B., Chisholm D.J., Campbell L.V. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993, 328:238-244.
139. 5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids 2005, 72:343-350.
140. Ginsberg B.H., Jabour J., Spector A.A. Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 1982, 690:157-164.
141. Somova L., Moodley K., Channa M.L., Nadar A. Dose-dependent effect of dietary fish-oil (n-3) polyunsaturated fatty acids on in vivo insulin sensitivity in rat. Methods Find Exp Clin Pharmacol 1999, 21:275-278.
142. Huang Y.-J., Fang V.S., Chou Y.-C., Kwok C.-F., Ho L- T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 1997, 46:1252-1258.
143. Mori Y., Murakawa Y., Katoh S., Hata S., Yokoyama J., Tajima N., et al. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism 1997, 46:1458-1464.
144. Anthony K., Reed L.J., Dunn J.T., Bingham E., Hopkins D., Marsden P.K., Amiel S.A. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance. The cerebral basis for impaired control of food intake in metabolic syndrome?. Diabetes 2006, 55:2986-2992.
145. Flores M.B.S., Fernandes M.F.A., Ropello E.R., Faria M.C., Ueno M., Velloso L.A., et al. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 2006, 55:2554-2561.
146. Spanswick D., Smith M.A., Groppi V.E., Logan S.D., Ashford M.L.J. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997, 390:521-525.
147. Harvey J., McKay N.G., Walker K.S., Van der Kay J., Downes C.P., Ashford M.L.J. Essential role of phosphoinositide 3-kinase in leptin-induced kATP channel activation in the rat CRI-GI insulinoma cell line. J Biol Chem 2000, 275:4660-4669.
148. Spanswick D., Smith M.A., Mirshamsi S., Routh V.H., Ashford M.L.J. Insulin activates ATP-sensitive K+ channels in hypothalamic neuronsof lean, but not obese rats. Nat Neurosci 2000, 3:757-762.
149. Loftus T.M., Jaworsky D.E., Frehywot G.L., Townsend C.A., Ronnett G.V., Lane M.D., Kuhajda F.P. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000, 288:2379-2381.
150. McGarry G.D., Mannaert G.P., Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977, 60:265-270.
151. Ruderman N.B., Saha A.K., Vavvas D., Witters L.A. Malonyl-CoA fuel sensing and insulin resistance. Am J Physiol Endocrinol Metab 1999, 276:E1-18.
152. Ramos E.J.B., Suzuki S., Meguid M.M., Laviano A., Sato T., Chen C., Das U.N. Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: pre- and post-tumor resection and at death. Surgery 2004, 136:270-276.
153. Stranahan A.M., Lee K., Martin B., Maudsley S., Golden E., Cutler R.G., Mattson M.P. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
154. Ryan A.S., Nicklas B.J. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004, 27:1699-1705.
155. Teixeira de Lemos E., Reis F., Baptista S., Pinto R., Sepodes B., Vala H., et al. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009, 25:330-339.
156. Das U.N. Anti-inflammatory nature of exercise. Nutrition 2004, 20:323-326.
157. Shi X., Stevens G.H., Foresman B.H., Stern S.A., Raven P.B. Autonomic nervous system control of the heart: endurance exercise training. Med Sci Sports Exerc 1995, 27:1406-1413.